1. Home >
  2. Investors >
  3. Private Equity Firm >
  4. United States >
  5. Connecticut >
  6. Ferrer Freeman & Co.

Ferrer Freeman Mergers and Acquisitions Summary

Private Equity Firm Profile

Ferrer Freeman’s most common sectors for investment arehealthcare services (34%) and medical products (24%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (58%) and venture (15%). In total, Ferrer Freeman has invested in 12 US states. Its largest (disclosed) acquisition occurred in 2007 when it acquired Reliant Renal Care for $50M.

The Firm’s most common exit type is trade sale (63%). Ferrer Freeman’s largest (disclosed) exit occurred in 2004 when it sold Sicor for $3.4B.

Sign-up to view Ferrer Freeman’s full profile and discover more middle-market private equity firm investors just like it.

M&A Summary

  • M&A Total Activity45
    • M&A Buy Activity21
    • M&A Sell Activity24
  • Total Sectors Invested 5
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 28

Ferrer Freeman & Co.

10 Glenville Street,
Greenwich, Connecticut 06831
United States
(203) 532-8011
www.ffandco.com

Ferrer Freeman & Co. (FFC) is a private equity firm that invests exclusively in healthcare companies generating sales minimum $20 to $200 million. FFC also invests in clinical products and outsourcing/infrastructure businesses serving the healthcare sector. FFC looks to commit $10 to $40 million per transaction and focuses primarily on growth capital financings and build-ups. However, the Firm will also selectively fund buyouts as well. Ferrer Freeman & Co. LLC was formed in 1995 and is based in Greenwich, Connecticut.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Medical Products, Staffing, Test/Measurement Equipment

Target Transaction Types: Buyout (LBO, MBO, MBI), Consolidation, Going Private, Growth Capital, Stake Purchase

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue 20 200
Target EBITDA - -
Investment Size 10 40
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 21 - - - - - 21
vol $86M $86M
Sell (0.0/yr) # 24 - - - - - 24
vol $10.6B $10.6B
  45

Most Recent M&A

Company Date Value Type
Aerocare Holdings, Inc. 2019-10-21 - Secondary Sale
Orlando, Florida · www.aerocareusa.com
K2M, Inc. 2018-08-30 1.4B USD Trade Sale
Leesburg, Virginia · www.k2m.com
Medical Depot, Inc. 2016-08-30 - Secondary Sale
Port Washington, New York · www.drivemedical.com
Ardent Health Partners, Inc. 2015-07-07 - Secondary Sale
Brentwood, Tennessee · www.ardenthealth.com
Genova Diagnostics, Inc. 2013-11-13 - Secondary Sale
Asheville, North Carolina · www.gdx.net
Amerita, Inc. 2012-12-13 - Trade Sale
Irvine, California · www.ameritaiv.com
Arcadia Solutions LLC 2012-11-14 - Buyout (LBO, MBO, MBI)
Boston, Massachusetts · www.arcadia.io
Preferred Care Partners, Inc. 2012-02-28 - Trade Sale
Miami, Florida · www.mypreferredcare.com
Ernest Health, Inc. 2012-01-31 400M USD Trade Sale
Mesquite, Texas · www.ernesthealth.com
Medical Depot, Inc. 2011-10-11 - Buyout (LBO, MBO, MBI)
Port Washington, New York · www.drivemedical.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services - - 7 (33%) 50M (58%)
Medical Products - - 5 (24%) -
Life Science - - 4 (19%) 26M (30%)
Information Technology - - 4 (19%) -
Insurance - - 1 (5%) 10M (11%)
Total - - 21 $86M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States - - 21 (100%) 86M (100%)
  Texas - - 5 (24%) -
  California - - 3 (14%) 26M (30%)
  Pennsylvania - - 2 (10%) 50M (58%)
  New Jersey - - 2 (10%) -
  Virginia - - 2 (10%) -
  Connecticut - - 1 (5%) 10M (11%)
  New York - - 1 (5%) -
  New Hampshire - - 1 (5%) -
  Massachusetts - - 1 (5%) -
  Illinois - - 1 (5%) -
  Utah - - 1 (5%) -
  Tennessee - - 1 (5%) -
Total - - 21 $86M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) - - 12 (57%) 50M (58%)
Venture - - 3 (14%) 36M (42%)
PIPE - - 3 (14%) -
Stake Purchase - - 2 (10%) -
Secondary Buyout - - 1 (5%) -
Total - - 21 $86M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 14 (58%) 7.2B (68%)
Secondary Sale 6 (25%) 3.1B (29%)
Trade Sale 2 (8%) 250M (2%)
IPO 1 (4%) -
Unknown 1 (4%) -
Total 24 $10.6B

Deal Values

buy # Total
< $100M 3 $86M
TOTAL $86M
Largest Reliant Renal Care, Inc.
$50M (2007-12-01)
sell # Total
> $1B 3 $7.9B
$100M to $1B 6 $2.7B
TOTAL $10.6B
Largest Sicor, Inc.
$3.4B (2004-01-22)

M&A Connections

Deals
Acquired from
Investor(s)
5%
1 (5%)
Exited to
Investor(s)
29%
7 (29%)
Strategic(s)
67%
16 (67%)

Investor Summary

Investor Type

Private Equity Firm

Size

Middle-Market

PE Assets

900M USD

Established

1995

Specialist/Generalist

Specialist

FAQ

When was Ferrer Freeman & Co. founded?

Ferrer Freeman & Co. was founded in 1995.

What type of investor is Ferrer Freeman & Co.?

Ferrer Freeman & Co. is a private equity firm.

Where is Ferrer Freeman & Co. headquartered?

Ferrer Freeman & Co. is headquartered in Greenwich, Connecticut.

How much capital does Ferrer Freeman & Co. have under management?

Ferrer Freeman & Co. has 900M USD under management.

Try Mergr Free — See This and 215,174+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 209K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal